The European regulation REACH (Registration, Evaluation and Authorization of Chemicals) has become effective and replaces the previous legislation in the European Union (EU).

PharmaZell pre-registered raw materials used in its synthetic routes, isolated intermediates and final drug substances, which are or may in the future not only be used in drug products, independent whether manufactured in European Union or imported from our subsidiaries outside of European Union.

In our own role as a downstream user we are and will also in the future be in close contact with our suppliers to ensure that our manufacturing process were not affected. Those products for which our suppliers completed their own pre-registration were excluded from our pre-registration list.

Having successfully finalized the pre-registration process we are now in a position to ensure the continued marketing and supply of our products. The full registration for any relevant substance can now proceed within the specified deadlines until 2018.